Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis : a prospective randomized trial

• SURREY ES

収録刊行物

• J Clin Endocrinol Metab

  J Clin Endocrinol Metab 75 558-563, 1992

詳細情報

• CRID: 1570009750668964352
• NII論文ID: 10021985248
• データソース種別:
  • CiNii Articles